C-Type Lectins and Immune Surveillance in ALD

C 型凝集素与 ALD 中的免疫监视

• 批准号: 10426861
• 负责人: Adam Kim
• 金额: $ 6.16万
• 依托单位: CLEVELAND CLINIC LERNER COM-CWRU
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10426861
• 关键词: Administrative Supplement; C-Type Lectins; COVID-19 pandemic; Clinic; Clinical Immunology; Data; Enrollment; Goals; Immunologic Surveillance; Leadership; Learning; Mentors; Patients; Reagent; Research; Work; career; career development; experimental study; pandemic disease; skills

Project Summary This Administrative Supplement will provide an additional year of mentored research to compensate for research progress and career development that was delayed due to the COVID-19 pandemic. The pandemic forced research labs at the Cleveland Clinic to reduce to a quarter or half capacity for the last year, reduced the number of patients enrolled in studies, and decreased access to many critical lab supplies including reagents. As a result, research focus had to be shifted to remote work, and many year 1 and year 2 research and career goals for the K99 were unmet. During this extra year, the candidate will be able to finish experiments that were put off due to the pandemic and continue to develop skills in clinical immunology, generate the sequencing data outlined in the proposal, and learn leadership skills to transition into independence.

项目摘要 这种行政补充剂将提供额外的指导研究，以补偿 研究进度和职业发展由于19号大流行而被推迟。大流行 克利夫兰诊所的强迫研究实验室将去年降低到四分之一或一半的容量，从而减少了 参加研究的患者人数，减少了包括试剂在内的许多关键实验室供应的机会。 结果，研究重点必须转移到远程工作，以及1年和第二年的研究和职业。 K99的目标尚未满足。在这一年中，候选人将能够完成实验 由于大流行而推迟，并继续发展临床免疫学的技能，生成测序数据 在提案中概述，学习领导技能以过渡到独立性。